These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17627038)

  • 1. Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor.
    Martínez C; García-Martín E; Alonso-Navarro H; Jiménez-Jiménez FJ; Benito-León J; García-Ferrer I; Vázquez-Torres P; Puertas I; Zurdo JM; López-Alburquerque T; Agúndez JA
    Neuromolecular Med; 2007; 9(2):195-204. PubMed ID: 17627038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations.
    Pedersen RS; Brasch-Andersen C; Sim SC; Bergmann TK; Halling J; Petersen MS; Weihe P; Edvardsen H; Kristensen VN; Brøsen K; Ingelman-Sundberg M
    Eur J Clin Pharmacol; 2010 Dec; 66(12):1199-205. PubMed ID: 20665013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.
    Suarez-Kurtz G; Genro JP; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Ribeiro-dos-Santos A; Romano-Silva MA; Santana I; Struchiner CJ
    Pharmacogenomics J; 2012 Jun; 12(3):267-76. PubMed ID: 21173785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the CYP2C monooxygenase enzyme subfamily shows no association with longevity in a German population.
    Flachsbart F; Ufer M; Kleindorp R; Nikolaus S; Schreiber S; Nebel A
    J Gerontol A Biol Sci Med Sci; 2011 Nov; 66(11):1186-91. PubMed ID: 21798861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
    Yasar U; Lundgren S; Eliasson E; Bennet A; Wiman B; de Faire U; Rane A
    Biochem Biophys Res Commun; 2002 Nov; 299(1):25-8. PubMed ID: 12435384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.
    Kudzi W; Dodoo AN; Mills JJ
    BMC Med Genet; 2009 Dec; 10():124. PubMed ID: 19954515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.
    Dorado P; Cavaco I; Cáceres MC; Piedade R; Ribeiro V; Llerena A
    Eur J Clin Pharmacol; 2008 Oct; 64(10):967-70. PubMed ID: 18548238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.
    Dreisbach AW; Japa S; Sigel A; Parenti MB; Hess AE; Srinouanprachanh SL; Rettie AE; Kim H; Farin FM; Hamm LL; Lertora JJ
    Am J Hypertens; 2005 Oct; 18(10):1276-81. PubMed ID: 16202848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
    García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
    Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
    Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
    Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotype structures of common variants of CYP2C8, CYP2C9, and ADRB1 genes in a South Indian population.
    Arun Kumar AS; Chakradhara Rao US; Umamaheswaran G; Ramu P; Kesavan R; Shewade DG; Balachandar J; Adithan C
    Genet Test Mol Biomarkers; 2011 Jun; 15(6):407-13. PubMed ID: 21375401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals.
    Haeggström S; Ingelman-Sundberg M; Pääbo S; Zeberg H
    Pharmacogenomics J; 2022 Jul; 22(4):247-249. PubMed ID: 35780191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates.
    Pimenoff VN; Laval G; Comas D; Palo JU; Gut I; Cann H; Excoffier L; Sajantila A
    Pharmacogenet Genomics; 2012 Dec; 22(12):846-57. PubMed ID: 23089684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
    Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
    Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global variation in CYP2C8-CYP2C9 functional haplotypes.
    Speed WC; Kang SP; Tuck DP; Harris LN; Kidd KK
    Pharmacogenomics J; 2009 Aug; 9(4):283-90. PubMed ID: 19381162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.
    Halling J; Petersen MS; Damkier P; Nielsen F; Grandjean P; Weihe P; Lundgren S; Lundblad MS; Brøsen K
    Eur J Clin Pharmacol; 2005 Aug; 61(7):491-7. PubMed ID: 16025294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression and function of CYP2C isoforms in human intestine and liver.
    Läpple F; von Richter O; Fromm MF; Richter T; Thon KP; Wisser H; Griese EU; Eichelbaum M; Kivistö KT
    Pharmacogenetics; 2003 Sep; 13(9):565-75. PubMed ID: 12972955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation.
    Chang TK; Yu L; Goldstein JA; Waxman DJ
    Pharmacogenetics; 1997 Jun; 7(3):211-21. PubMed ID: 9241661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
    Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
    Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C19 polymorphism and risk for essential tremor.
    Alonso-Navarro H; Martínez C; García-Martín E; Benito-León J; García-Ferrer I; Vázquez-Torres P; Puertas I; López-Alburquerque T; Agúndez JA; Jiménez-Jiménez FJ
    Eur Neurol; 2006; 56(2):119-23. PubMed ID: 16960452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.